BIOPHARMA

The BIOPHARMA online database and annual printed editions (last printed in 2007, then >1,600 pages, now would be >2,000 pages) provided unnmatched coverage from 1981 through 2011/12, the first 3 decades+ of modern biopharmaceuticals, particularly recombinant proteins. BIOPHARMA remains the only substantive information resource/reference ever published concerning biopharmaceutical agents and products.

Included all biopharmaceuticals (recombinant and other cultured proteins, monoclonal antibodies, vaccines, enzymes, blood/plasma products, radioimmune conjugates, cultured cells/tissues) in U.S. and European markets through 2011/12.

Included much unique bioprocessing, competitive, technological, marketing, patent, and regulatory intelligence available nowhere else (potentially invaluable information), including from unique sources (e.g., >200 FOI requests fulfilled by FDA).

Also see BIOPHARMA: U.S. Approvals 2002-2021.

BIOPHARMA™: Biopharmaceutical Products in the U.S. and European Markets [Database now archived, no longer online].

BIOPHARMA™: Biopharmaceutical Products in the U.S. and European Markets
[Database now archived, no longer online].